김재현 (성균관대학교 의과대학, 삼성서울병원)님 | 한빛사연구자 > 한빛사

Continuous glucose monitoring and risks of acute and chronic diabetes-related complications and mortality in adults with type 1 diabetes: a nationwide cohort study

Diabetologia, Mar 21 2026, | https://doi.org/10.1007/s00125-026-06709-2

2026-03
의약학
한빛사논문

High incidence of eating disorders in individuals with type 2 diabetes and their association with cardiovascular and mortality risks

Diabetologia, Nov 26 2025, | https://doi.org/10.1007/s00125-025-06615-z

2025-11
의약학
한빛사논문

[Editorial Comment] Statins in Type 1 Diabetes: Bridging the Evidence Gap With Target Trial Emulation

J. Am. Coll. Cardiol., 8 September 2025 | https://www.jacc.org/doi/10.1016/j.jacc.2025.07.021

2025-09
의약학
한빛사논문

Higher suicide risk in type 1 diabetes compared to cancer and the general population in Korea

J. Intern. Med., Feb 11 2025, | https://doi.org/10.1111/joim.20071

2025-02
의약학
한빛사논문

A randomized controlled trial of an app-based intervention on physical activity and glycemic control in people with type 2 diabetes

BMC Med., 01 May 2024;185 (2024) | https://doi.org/10.1186/s12916-024-03408-w

2024-05
의약학
한빛사논문

Adrenalectomy Improves Body Weight, Glucose, and Blood Pressure Control in Patients with Mild Autonomous Cortisol Secretion: Results of an RCT by the Co-work of Adrenal Research (COAR) Study

Ann. Surg., Dec 21 2023, | https://doi.org/10.1097/SLA.0000000000006183

2023-12
의약학
한빛사논문

An Integrated Digital Health Care Platform for Diabetes Management With AI-Based Dietary Management: 48-Week Results From a Randomized Controlled Trial